Research AppraisalRandomised Controlled Trial

Intravascular Imaging- vs Angiography-Guided Complex PCI: 5-Year Outcomes From a Randomized Trial

Journal of the American College of CardiologyLee, Joo Myung, Kim, Onyou, Song, Young Bin et al.28 Apr 2026DOI

Clinical Snapshot

75CEBM
Evidence: ModerateRandomised Controlled Trial

PICO Framework

P — PopulationPatients with complex coronary artery lesions undergoing percutaneous coronary intervention (PCI)
I — InterventionIntravascular imaging-guided PCI
C — ComparatorAngiography-guided PCI
O — OutcomesComposite of cardiac death, target vessel-related myocardial infarction, or clinically driven target vessel revascularization at 5-year follow-up

Bottom Line

This large Korean multicentre RCT demonstrates that intravascular imaging guidance during complex PCI significantly reduces major adverse cardiac events compared to angiography guidance alone over 5 years. The 32% relative risk reduction (HR 0.68) translates to preventing one adverse event for every 23 patients treated with imaging guidance. While the open-label design introduces bias risk, the magnitude and consistency of benefit across cardiac death, MI, and revascularization endpoints is compelling. For Australian interventional cardiologists, this supports routine use of intravascular imaging (IVUS/OCT) in complex PCI cases, particularly given the technology's availability in major centres. The long-term follow-up strengthens confidence in sustained clinical benefit, though cost-effectiveness analysis would inform broader implementation strategies.

Evidence: Moderate

Key Findings

  • P Value: P = 0.009

  • Effect Size: 10.5% vs 14.9% (absolute risk reduction 4.4%)

  • Primary Outcome: Composite of cardiac death, target vessel-related MI, or clinically driven target vessel revascularization

  • Nnt Or Sensitivity: NNT = 23 (number needed to treat to prevent one primary endpoint)

  • Confidence Interval: HR 0.68 (95% CI: 0.51-0.91)

Clinical Application

Requires intravascular imaging capability (IVUS/OCT) and trained operators Applicable to Australian practice; intravascular imaging available in major cardiac centres; may influence PBS reimbursement considerations for imaging-guided procedures Patients with complex coronary lesions requiring PCI in tertiary cardiac centres

Abstract

BACKGROUND: Data regarding long-term outcomes of intravascular imaging-guided percutaneous coronary intervention (PCI) for complex coronary artery lesions, compared with angiography-guided PCI, remain limited. OBJECTIVES: The authors sought to present long-term clinical outcomes of intravascular imaging-guided PCI compared with angiography-guided PCI in patients with complex coronary artery lesions. METHODS: Eligible patients with complex coronary artery lesions were randomly assigned 2:1 to undergo intravascular imaging-guided PCI or angiography-guided PCI in this prospective multicenter open-label superiority trial performed in South Korea. The primary endpoint was a composite of cardiac death, target vessel-related myocardial infarction, or clinically driven target vessel revascularization. RESULTS: A total of 1,639 patients underwent randomization with 1,092 assigned to imaging-guided PCI and 547 assigned to angiography-guided PCI. At a median follow-up of 5.3 years (Q1-Q3: 4.4-6.2 years), the primary endpoint occurred in 109 of 1,092 patients (10.5%) in the intravascular imaging-guided PCI group and 78 of 547 patients (14.9%) in the angiography-guided PCI group (HR: 0.68; 95% CI: 0.51-0.91; P = 0.009). Cardiac death or target vessel-related myocardial infarction occurred in 78 patients (7.6%) in the intravascular imaging-guided PCI group and in 56 patients (10.7%) in the angiography-guided PCI group, clinically driven target vessel revascularization in 45 (4.4%) and 32 (6.2%), and definite stent thrombosis in 1 (0.1%) and 4 (0.7%), respectively. There were no apparent differences in procedure-related safety events between the groups. CONCLUSIONS: In patients with complex coronary artery lesions undergoing PCI, intravascular imaging guidance reduced the risk of a composite of cardiac death, target vessel-related myocardial infarction, or clinically driven target vessel revascularization at median follow-up of 5.3 years, compared to angiography guidance. (Intravascular Imaging- Versus Angiography-Guided Percutaneous Coronary Intervention for Complex Coronary Artery Disease [RENOVATE-COMPLEX-PCI]; NCT03381872).

References

  1. 1.Lee, J. M., Kim, O., Song, Y. B., Lee, J.-Y., Lee, S.-J., Lee, S. Y., Kim, S. M., Yun, K. H., Cho, J. Y., Kim, C. J., Ahn, H.-S., Nam, C.-W., Yoon, H.-J., Park, Y. H., Lee, W. S., Jeong, J.-O., Song, P. S., Doh, J.-H., Jo, S.-H., Yoon, C.-H., Kang, M. G., Koh, J.-S., Lee, K. Y., Lim, Y.-H., Cho, Y.-H., Cho, J.-M., Jang, W. J., Chun, K.-J., Choi, K. H., Park, T. K., Yang, J. H., Choi, S.-H., Gwon, H.-C., & Hahn, J.-Y. (2026). Intravascular imaging- vs angiography-guided complex PCI: 5-year outcomes from a randomized trial. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2026.01.035
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service